megestrol acetate has been researched along with Metastase in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (41.46) | 18.7374 |
1990's | 15 (36.59) | 18.2507 |
2000's | 6 (14.63) | 29.6817 |
2010's | 2 (4.88) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Agar, MR; Clark, K; Currow, DC; Fazekas, B; Glare, P; Louw, S; Martin, P | 1 |
Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J | 1 |
Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL | 1 |
Goldray, D; Inbar, MJ; Ron, IG; Soyfer, V; Weisman, Y | 1 |
Ali, SM; Allard, JW; Carney, W; Chinchilli, VM; Demers, L; Engle, L; Harvey, HA; Leitzel, K; Lipton, A | 1 |
Rose, C | 1 |
Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T | 1 |
Blumenschein, GR; Buzdar, AU; Ross, MB | 1 |
Adlercreutz, H; Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Docter, R; Hop, WC; Klijn, JG; Lamberts, SW; van Gilse, HA | 1 |
Alexieva-Figusch, J; Blankenstein, MA; de Jong, FH; Lamberts, SW | 1 |
Bukowski, RM; James, RE; Montie, JE; Stewart, BH; Straffon, RA | 1 |
Dawson, NA; McLeod, DG | 1 |
Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D | 1 |
Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
Burns, I; Byrne, M; Coates, A; Gebski, V; Gill, PG; Levi, J; Snyder, R | 1 |
Cobau, CD; Declercq, K; Ingle, JN; Neuberg, D; Tormey, DC | 1 |
Gebbia, N; Gebbia, V; Testa, A | 1 |
Buzdar, AU; Hortobagyi, GN; Plourde, PV | 1 |
Blackledge, GR; Earl, H; Keen, C; Spooner, D; Stuart, NS; Taylor, AR; Tyrell, C; Warwick, J; Webster, DJ | 1 |
Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B | 1 |
Agelaki, S; Chalkiadakis, G; Georgoulias, V; Kakolyris, S; Kalbakis, K; Koukourakis, M; Samonis, G; Sanidas, E; Tsiftsis, D; Vlachonicolis, J | 1 |
Joy, AA; Mackey, JR | 1 |
Arkhipov, A; Bajetta, E; Cervek, J; di Salle, E; Dirix, LY; Dugardyn, JL; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Mennel, RG; Miller, LL; Nasurdi, C; Piscitelli, G; Polli, A; Zilembo, N | 1 |
Cruz, JM; Muss, HB | 1 |
Venner, P | 1 |
Cruz, JM; Muss, HB; Russell, G | 1 |
Brenner, BG; Margolese, RG | 1 |
Brockschmidt, JK; Cruz, JM; Evans, GW; Muss, HB | 1 |
Albert, JD; Geller, J | 1 |
Soloway, MS | 1 |
Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE | 1 |
Becher, R; Miller, AA; Schmidt, CG | 1 |
Blossey, HC; Emrich, D; Nagel, GA; Wander, HE | 1 |
Glick, JH; Haller, DG | 1 |
Black, WR; Capizzi, RL; Christian, R; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; Paschold, EH; Powell, BL; Wells, HB | 1 |
Abrams, J; Aisner, J; Tait, N; Tchekmedyian, NS | 1 |
Gale, KE; Hahn, RG; Horton, J; Keller, AM; Knuiman, M; Rosenbluth, RJ; Tormey, DC; Vogel, H | 1 |
Allegra, JC | 1 |
Crombie, C; Dalley, D; Devine, R; Page, J; Raghavan, D; Rosen, M; Woods, R | 1 |
Allegra, JC; Bertino, J; Bonomi, P; Byrne, P; Carpenter, J; Catalano, R; Creech, R; Dana, B; Durivage, H; Einhorn, L | 1 |
Alexieva-Figusch, J; Blonk-vd Wijst, J; Klijn, JG; van Gilse, HA; Van Putten, WL | 1 |
4 review(s) available for megestrol acetate and Metastase
Article | Year |
---|---|
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
High-dose progestin therapy for metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Megestrol; Megestrol Acetate; Neoplasm Metastasis | 1992 |
Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
Topics: Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostatic Neoplasms | 1992 |
Adrenal androgen blockade in relapsed prostate cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Castration; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Prostate; Prostatic Neoplasms | 1985 |
19 trial(s) available for megestrol acetate and Metastase
Article | Year |
---|---|
A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer.
Topics: Aged; Aged, 80 and over; Anorexia; Appetite; Appetite Stimulants; Australia; Dexamethasone; Disease Management; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Quality of Life; Treatment Outcome | 2021 |
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen | 2014 |
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Mucin-1; Neoplasm Metastasis; Prognosis; Receptor, ErbB-2; Retrospective Studies | 2002 |
Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
Topics: Administration, Oral; Aged; Blood Glucose; Breast Neoplasms; Cortodoxone; Drug Administration Schedule; Estradiol; Female; Humans; Insulin; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin | 1984 |
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Survival Rate; Tamoxifen | 1993 |
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Survival Rate | 1996 |
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Topics: Aged; Anorexia; Appetite; Body Weight; Cachexia; Dose-Response Relationship, Drug; Female; Humans; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms; Prospective Studies; Syndrome | 1996 |
A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Survival Rate; Tamoxifen; Time Factors; Treatment Failure | 1996 |
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure | 1997 |
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Estrogen Antagonists; Female; Humans; Megestrol Acetate; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Staging; Receptors, Estrogen; Survival Analysis; Tamoxifen; Vincristine | 1999 |
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study.
Topics: Administration, Oral; Aged; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Survival Analysis; Treatment Outcome | 2000 |
High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis | 1992 |
Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Topics: Blood Pressure; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Weight Gain | 1990 |
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation | 1987 |
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Receptors, Cell Surface; Testosterone | 1985 |
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Remission Induction; Tamoxifen | 1988 |
Megestrol acetate: a new role in the treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1987 |
Metastatic breast cancer: preliminary results with oral hormonal therapy.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1985 |
18 other study(ies) available for megestrol acetate and Metastase
Article | Year |
---|---|
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2013 |
A low-dose adrenocorticotropin test reveals impaired adrenal function in cancer patients receiving megestrol acetate therapy.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Female; Humans; Hydrocortisone; Male; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms | 2002 |
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome | 2005 |
Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Prognosis; Tamoxifen | 1982 |
Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Sex Hormone-Binding Globulin; Tamoxifen; Thyrotropin-Releasing Hormone | 1984 |
A critical review of immunotherapy of disseminated renal adenocarcinoma.
Topics: Adenocarcinoma; BCG Vaccine; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Neoplasms; Lomustine; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Nitrosourea Compounds; Transfer Factor | 1982 |
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
Topics: Aged; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome | 1995 |
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53 | 1995 |
Aromatase inhibitors in metastatic breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles | 1996 |
Letrozole in second-line therapy of advanced breast cancer: more questions than answers.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Europe; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Nitriles; Palliative Care; Postmenopause; Treatment Outcome; Triazoles | 2001 |
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytotoxicity, Immunologic; Humans; Immunity, Innate; Killer Cells, Natural; Leukocyte Count; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Neoplasm Staging; Tamoxifen | 1991 |
Treatment of prostatic cancer. Newer forms of androgen deprivation.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1986 |
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay | 1988 |
Progestational agents in advanced breast cancer: an overview.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen | 1986 |
High-dose megestrol acetate in the treatment of advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Metastasis | 1988 |
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
Topics: Aged; Humans; Liver; Male; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms | 1987 |
Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Topics: Administration, Oral; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Prognosis; Tamoxifen | 1985 |